id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-287824-zg5akivn	Chan, Yinghan	Advanced drug delivery systems can assist in managing influenza virus infection: A hypothesis	2020-09-24		.txt	text/plain	1159	24	-1	Vaccine Anti-455 bacterial activity of inorganic nanomaterials and their antimicrobial peptide conjugates 456 against resistant and non-resistant pathogens Perspectives and 459 advancements in the design of nanomaterials for targeted cancer theranostics Microparticles as Vaccine Adjuvants and Delivery Systems Investigation of 465 tunable acetalated dextran microparticle platform to optimize M2e-based influenza 466 vaccine efficacy Molecular assembly and application of biomimetic microcapsules Hybrid inorganic-organic capsules for eficient intracellular delivery of novel siRNAs 472 against influenza A (H1N1) virus infection Biodegradable Polyelectrolyte/Silica Composite Microcapsules as Carriers for Small 476 Application of dendrimers for the treatment of 479 infectious diseases Nanoparticle vaccines against infectious diseases Delivery Vehicles for Active Phytoconstituents Emerging Trends 492 in Nanomedicine for Topical Delivery in Skin Disorders: Current and Translational 493 Oligonucleotide 495 therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory 496 diseases Emerging trends in 498 the novel drug delivery approaches for the treatment of lung cancer Interactions 501 with the macrophages: An emerging targeted approach using novel drug delivery 502 systems in respiratory diseases Gene Delivery by PAMAM Dendrimer 505 Conjugated with the Nuclear Localization Signal Peptide Derived from Influenza B 506 Identification of biomarkers and genetic approaches toward chronic obstructive 510 pulmonary disease Inhibition of influenza A virus infection in vitro by saliphenylhalamide-loaded 513 porous silicon nanoparticles Enhanced inhibition of influenza virus infection 516 by peptide-noble-metal nanoparticle conjugates Development of an adjuvanted nanoparticle vaccine against influenza virus, an 520 in vitro study Pulmonary surfactant-biomimetic 523 nanoparticles potentiate heterosubtypic influenza immunity Protein Nanoparticle Immunization Induces Broad Cross-Protection against 527 Different Influenza Viruses in Mice Virus-mimetic polymer 530 nanoparticles displaying hemagglutinin as an adjuvant-free influenza vaccine Porous gold nanoparticles for 533 attenuating infectivity of influenza A virus Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: 537 Another emerging application of nanomedicine Phase 3 Pivotal Trial of NanoFlu TM in Older Adults Editorial: Advances and challenges in nanomedicine Nanoethics: From utopian dreams and apocalyptic nightmares towards a 543 more balanced view The authors declare no conflict of interest, financial or otherwise. Single-371 dose mucosal immunization with a candidate universal influenza vaccine provides 372 rapid protection from virulent H5N1, H3N2 and H1N1 viruses Exploiting Nanotechnology to Target Viruses Universal influenza vaccines: from viruses to 378 nanoparticles Nanotherapeutic Anti-influenza Solutions: Current Knowledge and Future Challenges Influenza antivirals and resistance: The next 10 384 years?	cache/cord-287824-zg5akivn.txt	txt/cord-287824-zg5akivn.txt
